RAD140 is a nonsteroidal selective androgen receptor modulator, or SARM, that resulted from an internal drug discovery program that began in 2005. RAD140 has demonstrated potent anabolic activity on muscle and bone in preclinical studies and has completed 28-day preclinical toxicology Cstudies in both rats and monkeys. Because of its high anabolic efficacy, receptor selectivity, potent oral activity and long duration half-life, RAD140 has clinical potential Cin a number of indications where the increase in lean muscle mass and/or bone density is beneficial, such as treating the weight loss due to cancer cachexia, muscle frailty and osteoporosis.
1. Enhanced speed, stamina and endurance during high-intensity workouts.
2. Faster buildup of muscular tissues that helps you achieve more gains in a shorter period of time.
3. ReduceS the androgenic side effects that can be potentially caused. This makes its usage way safer and more effective compared to traditional prohormones and anabolic steroids available commercially.